Members |
targetComponentId |
överdos av medel mot magsyra |
Proton pump inhibitor overdose |
Anti-gastric acid drug poisoning |
Poisoning by drug AND/OR medicinal substance |
Anti-hyaluronidase assay |
Antistreptococcal hyaluronidase titer |
Anti-hyaluronidase assay |
Anti-hyaluronidase assay |
biverkning av nasala antiinfektiva medel |
Anti-infectives adverse reaction |
Anti-infective preparations |
Medicinal product acting as antiinfective agent (product) |
Anti-nRNP antibody |
Heterogeneous small ribonucleoprotein antibody (substance) |
Anti-nRNP antibody |
U1 small ribonucleoprotein antibody (substance) |
Anti-nRNP antibody |
Ribosomal ribonucleoprotein antibody |
Anti-nRNP antibody |
Small ribonucleoprotein antibody (substance) |
Anti-nuclear antibody measurement |
Measurement of deoxyribonucleoprotein antibody (procedure) |
Anti-nuclear antibody measurement |
ANA measurement |
Anti-nuclear: ([factor] or [antibody] & level) |
Antinuclear antibody |
antitrombosprofylax |
Administration of prophylactic platelet aggregation inhibitor (procedure) |
Anti-platelet prophylaxis |
Administration of prophylactic platelet aggregation inhibitor (procedure) |
Anti-platelet prophylaxis |
Administration of prophylactic platelet aggregation inhibitor (procedure) |
Anti-tetanus immunoglobulin injection |
Administration of tetanus antitoxin (procedure) |
Anti-tetanus immunoglobulin injection |
Infusion of tetanus antitoxin (procedure) |
Anti-tetanus immunoglobulin injection |
Injection of tetanus antitoxin (procedure) |
Anti-tetanus immunoglobulin injection |
Anti-tetanus immunoglobulin injection (procedure) |
Anti-varic-Zoster immunoglob |
Varicella-zoster virus antibody-containing product |
biverkning av antiallergikum |
Corticosteroids adverse reaction |
biverkning av antiallergikum |
Adverse reaction to antihistamines |
överdos av antiallergikum |
Overdose of histamine receptor antagonist (disorder) |
förgiftning orsakad av antiallergikum |
Poisoning caused by corticosteroid and/or corticosteroid derivative |
förgiftning orsakad av antiallergikum |
Antihistamine poisoning (disorder) |
läkemedelsprofylax mot amöbainfektion |
Administration of prophylactic drug or medicament (procedure) |
Antiamoebic drug prophylaxis |
Administration of prophylactic drug or medicament (procedure) |
antibabesial |
Antiprotozoal |
Antibiotic antifungal |
Antifungal agent |
antibiotikatäckning, tandläkarvård |
Administration of prophylactic antibiotic (procedure) |
Antibiotic cover - surgery |
Administration of prophylactic antibiotic (procedure) |
antibiotikatäckning, kirurgisk åtgärd |
Administration of prophylactic antibiotic (procedure) |
Antibiotic enterocolitis |
Necrotizing enterocolitis in fetus OR newborn |
Antibiotic enterocolitis |
Perinatal necrotizing enterocolitis (disorder) |
Antibiotic enterocolitis |
Neonatal necrotizing enterocolitis |
Antibiotic enterocolitis |
Antibiotic enterocolitis (disorder) |
antibiotikautlöst pseudomembranös enterokolit |
Clostridium difficile colitis (disorder) |
Antibiotic prophylaxis (& [dental cover]) |
Administration of prophylactic antibiotic (procedure) |
Antibiotic prophylaxis (& [dental cover]) |
Administration of prophylactic antibiotic (procedure) |
antikropp mot influensavirus A från svin |
Influenza A virus antibody (substance) |
antikropp mot porcint influensavirus A |
Influenza A virus antibody (substance) |
antikropp mot Streptococcus pneumoniae 18 |
Antibody to Streptococcus pneumoniae Danish serotype 18F (substance) |
Antibody to tissue specific antigen measurement |
Antibody to tissue specific antigen measurement |
Antibody to tissue specific antigen measurement |
Antibody to tissue specific organ measurement |
Anticholinergic bronchodilators |
Medicinal product acting as bronchodilator (product) |
Anticholinergic bronchodilators |
Product containing acetylcholine receptor antagonist (product) |
Anticholinesterases used in surgery |
Product containing acetylcholinesterase inhibitor (product) |
Anticoagulant agonist poisoning NOS |
Poisoning by anticoagulant |
Anticoagulant monitoring |
Warfarin monitoring |
Anticoagulant monitoring (& [Warfarin]) |
Anticoagulant drug monitoring |
Anticoagulant monitoring |
Anticoagulant drug monitoring |
Anticoagulant monitoring (& [Warfarin]) |
Warfarin monitoring |
Anticoagulant prophylaxis |
Administration of prophylactic low dose heparin |
Anticoagulant prophylaxis |
Administration of prophylactic anticoagulant (procedure) |
Anticonvulsant or antiparkinsonian drug |
Antiparkinson agent |
Anticonvulsant or antiparkinsonian drug |
Medicinal product acting as anticonvulsant agent (product) |
Antidiuretic hormone antagon. [no drugs here] |
Medicinal product containing tetracycline structure and acting as antibacterial agent (product) |
Antidiuretic hormone antagon. [no drugs here] |
Product containing demeclocycline (medicinal product) |
Antiepileptic and sedative-hypnotic drug |
Medicinal product acting as anticonvulsant agent (product) |
Antiepileptic and sedative-hypnotic drug |
Medicinal product acting as hypnotic (product) |
Antiepileptic and sedative-hypnotic drug |
Medicinal product acting as sedative (product) |
Antifibrinolytic drugs and hemostatics |
Hemostatic agent |
Antifibrinolytic drugs and hemostatics |
Thrombolytic agent |
antifilarial |
Anthelmintic (disposition) |
antifilariprofylax |
Administration of prophylactic antihelminth (procedure) |
antifilarial behandlingsfunktion |
Anthelmintic therapeutic role |
Antifungal antibiotic |
Antifungal agent |
Antifungal drugs |
Antifungal agent |
Antifungal preparation |
Antifungal agent |
Antifungal susceptibility test |
Antifungal susceptibility test |
Antifungal susceptibility test |
Antibiotic sensitivity, fungus |
antigen från värmeinaktiverad Vibrio cholerae O1, serogrupp Ogawa, klassisk biotyp |
Antigen of inactivated whole Vibrio cholerae serogroup O1 serotype Ogawa biotype classical (substance) |
antigen från inaktiverat humant alfaherpesvirus 3 |
Antigen of inactivated whole Human alphaherpesvirus 3 (substance) |
antigen från inaktiverat influensavirus A, subtyp H1N1 |
Influenza A virus subtype H1N1 antigen |
antigen från inaktiverat influensavirus A, subtyp H3N2 |
Influenza A virus subtype H3N2 antigen |
antigen från inaktiverat influensavirus B, victorialinjen |
Influenza B virus Victoria lineage antigen |
antigen från inaktiverat influensavirus B, yamagatalinjen |
Influenza B virus Yamagata lineage antigen |
antigen från inaktiverat influensavirus |
Influenza virus antigen |
antigen från inaktiverat poliovirus |
Inactivated whole Human poliovirus antigen |
antigen från levande poliovirus |
Antigen of live attenuated Human poliovirus (substance) |
antigen från levande försvagad Bacillus Calmette-Guerin |
Bacillus Calmette-Guerin antigen |
antigen från svininfluensavirus |
Influenza A virus antigen |
Antigiardial drugs |
Antiprotozoal agent |
Antihypertensives+barbiturates |
Product containing barbiturate (product) |
Antihypertensives+barbiturates |
Hypotensive agent |
antileishmanial |
Antiprotozoal |
Antileishmanial drug |
Antiprotozoal agent |
Antilipemic and antiarteriosclerotic poisoning NOS |
Poisoning by drug AND/OR medicinal substance |
antimikrobiell |
Antiprotozoal |
antimikrobiell |
Antibacterial (disposition) |
antimikrobiell |
Antiviral (disposition) |
antimikrobiell |
Antifungal |
resistent organism |
Antimicrobial resistant fungi (organism) |
resistent organism |
Antimicrobial resistant virus (organism) |
resistent organism |
Antimicrobial resistant bacteria (organism) |
antimikrobiell mjuk korrigerande kontaktlins, engångs, dagligt byte |
Antimicrobial soft corrective contact lens (physical object) |
antimikrobiellt mottaglig organism |
Antimicrobial susceptible bacteria (organism) |
Antimitochondrial autoantibod. (& level) |
Antibody to mitochondria measurement |
biverkning av medel mot protozoer innehållande antimon |
Adverse reaction to antimony and/or antimony compound |
biverkning av medel mot protozoer innehållande antimon |
Antiprotozoal drug adverse reaction |